The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
902
August 6, 1993
View Complete Issue         Table of Contents 2019 
Desogestrel - A New Progestin for Oral Contraception
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Desogestrel - A New Progestin for Oral Contraception
August 6, 1993 (Issue: 902)
Desogen (Organon) and Ortho-Cept (Ortho), two oral contraceptives each containing a low dose (30 mcg) of the estrogen ethinyl estradiol plus 150 mcg of the progestin desogestrel, were recently approved by the US Food and Drug Administration for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Desogestrel - A New Progestin for Oral Contraception
Article code: 902c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.